FIN
Healthcare & Life Sciences
Transformation is the key to remaining competitive in healthcare and the life sciences.
With ageing populations, ever growing costs, and the rate of technological innovation skyrocketing, the Life Sciences and Healthcare industries are in the middle of enormous and disruptive changes.
The life sciences industry has been turned on its head as escalating research costs and patent losses forced big pharmaceutical players to aggressively pursue radical M&A strategies, whilst nimble biotech, medical device and diagnostics manufacturers are busy defining the next era of precision and targeted medicine - an era which has barely begun and one in which the need to be ever more innovative is a constant reality.
For healthcare providers, shrinking budgets and increasing expectations have created a challenging environment where payors and providers must reinvent the patient care model. Moreover, technological innovation and the developing role of the patient will drive transformation.
To thrive in this competitive and turbulent landscape, healthcare organisations and life sciences firms require exceptional leaders. Odgers Berndtson’s life sciences and healthcare practices support organisations in recruiting transformational leaders, with the ambition and strategic vision to pursue new opportunities.
